Ivantis
AcquiredIrvine, United States · Founded 2007
- Headquarters
- Irvine
- Founded
- 2007
- Business Model
- B2B
- Website
- ivantisinc.com
- Last Round
- Series BJan 2017
- Rounds
- 3
- Acquired by
- Alcon Inc.Nov 2021
About
Ivantis was a medical device company developing the Hydrus Microstent, a minimally invasive glaucoma surgery (MIGS) device designed to lower intraocular pressure in patients with primary open-angle glaucoma. The company's device received FDA clearance and was subsequently acquired by Alcon in January 2022 for $475 million.
Summary
Ivantis is a Healthcare company based in Irvine, United States, founded in 2007. Its most recent funding was a Series B round in Jan 2017. Investors include Alcon, New Enterprise Associates and Foresite Capital.
Funding History
Nov 2021
Sign up to see all 4 rounds
Series B through Acquisition — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
S4 Medical develops FDA-cleared devices that help physicians protect the esophagus during cathete...
Neko Health delivers preventive health scans that combine skin, heart, blood, and body measuremen...
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...
Healthcare cost management company providing data analytics and network-based payment solutions t...
American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/ivantis"><img src="https://indexed.vc/api/badge/company/ivantis" alt="Ivantis on Indexed.vc" width="260" height="76" /></a>